Sergey A Krupenko1, Shelley A Cole2, Ruixue Hou1, Karin Haack2, Sandra Laston3,4, Nitesh R Mehta5,6, Anthony G Comuzzie7, Nancy F Butte5,6, V Saroja Voruganti1. 1. Department of Nutrition and Nutrition Research Institute, University of North Carolina at Chapel Hill, Kannapolis, NC, USA. 2. Population Health Program, Texas Biomedical Research Institute, San Antonio, TX, USA. 3. Department of Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA. 4. South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA. 5. Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. 6. USDA/ARS Children Nutrition Research Center, Baylor College of Medicine, Houston, TX, USA. 7. The Obesity Society, Silver Spring, MD, USA.
Abstract
BACKGROUND: Glycine is a proteogenic amino acid that is required for numerous metabolic pathways, including purine, creatine, heme, and glutathione biosynthesis. Glycine formation from serine, catalyzed by serine hydroxy methyltransferase, is the major source of this amino acid in humans. Our previous studies in a mouse model have shown a crucial role for the 10-formyltetrahydrofolate dehydrogenase enzyme in serine-to-glycine conversion. OBJECTIVES: We sought to determine the genomic influence on the serine-glycine ratio in 803 Hispanic children from 319 families of the Viva La Familia cohort. METHODS: We performed a genome-wide association analysis for plasma serine, glycine, and the serine-glycine ratio in Sequential Oligogenic Linkage Analysis Routines while accounting for relationships among family members. RESULTS: All 3 parameters were significantly heritable (h2 = 0.22-0.78; P < 0.004). The strongest associations for the serine-glycine ratio were with single nucleotide polymorphisms (SNPs) in aldehyde dehydrogenase 1 family member L1 (ALDH1L1) and glycine decarboxylase (GLDC) and for glycine with GLDC (P < 3.5 × 10-8; effect sizes, 0.03-0.07). No significant associations were found for serine. We also conducted a targeted genetic analysis with ALDH1L1 exonic SNPs and found significant associations between the serine-glycine ratio and rs2886059 (β = 0.68; SE, 0.25; P = 0.006) and rs3796191 (β = 0.25; SE, 0.08; P = 0.003) and between glycine and rs3796191 (β = -0.08; SE, 0.02; P = 0.0004). These exonic SNPs were further associated with metabolic disease risk factors, mainly adiposity measures (P < 0.006). Significant genetic and phenotypic correlations were found for glycine and the serine-glycine ratio with metabolic disease risk factors, including adiposity, insulin sensitivity, and inflammation-related phenotypes [estimate of genetic correlation = -0.37 to 0.35 (P < 0.03); estimate of phenotypic correlation = -0.19 to 0.13 (P < 0.006)]. The significant genetic correlations indicate shared genetic effects among glycine, the serine-glycine ratio, and adiposity and insulin sensitivity phenotypes. CONCLUSIONS: Our study suggests that ALDH1L1 and GLDC SNPs influence the serine-to-glycine ratio and metabolic disease risk.
BACKGROUND: Glycine is a proteogenic amino acid that is required for numerous metabolic pathways, including purine, creatine, heme, and glutathione biosynthesis. Glycine formation from serine, catalyzed by serine hydroxy methyltransferase, is the major source of this amino acid in humans. Our previous studies in a mouse model have shown a crucial role for the 10-formyltetrahydrofolate dehydrogenase enzyme in serine-to-glycine conversion. OBJECTIVES: We sought to determine the genomic influence on the serine-glycine ratio in 803 Hispanic children from 319 families of the Viva La Familia cohort. METHODS: We performed a genome-wide association analysis for plasma serine, glycine, and the serine-glycine ratio in Sequential Oligogenic Linkage Analysis Routines while accounting for relationships among family members. RESULTS: All 3 parameters were significantly heritable (h2 = 0.22-0.78; P < 0.004). The strongest associations for the serine-glycine ratio were with single nucleotide polymorphisms (SNPs) in aldehyde dehydrogenase 1 family member L1 (ALDH1L1) and glycine decarboxylase (GLDC) and for glycine with GLDC (P < 3.5 × 10-8; effect sizes, 0.03-0.07). No significant associations were found for serine. We also conducted a targeted genetic analysis with ALDH1L1 exonic SNPs and found significant associations between the serine-glycine ratio and rs2886059 (β = 0.68; SE, 0.25; P = 0.006) and rs3796191 (β = 0.25; SE, 0.08; P = 0.003) and between glycine and rs3796191 (β = -0.08; SE, 0.02; P = 0.0004). These exonic SNPs were further associated with metabolic disease risk factors, mainly adiposity measures (P < 0.006). Significant genetic and phenotypic correlations were found for glycine and the serine-glycine ratio with metabolic disease risk factors, including adiposity, insulin sensitivity, and inflammation-related phenotypes [estimate of genetic correlation = -0.37 to 0.35 (P < 0.03); estimate of phenotypic correlation = -0.19 to 0.13 (P < 0.006)]. The significant genetic correlations indicate shared genetic effects among glycine, the serine-glycine ratio, and adiposity and insulin sensitivity phenotypes. CONCLUSIONS: Our study suggests that ALDH1L1 and GLDC SNPs influence the serine-to-glycine ratio and metabolic disease risk.
Authors: Remya R Nair; Henna Koivisto; Kimmo Jokivarsi; Ilkka J Miinalainen; Kaija J Autio; Aki Manninen; Pekka Poutiainen; Heikki Tanila; J Kalervo Hiltunen; Alexander J Kastaniotis Journal: J Neurosci Date: 2018-09-28 Impact factor: 6.167
Authors: Wieke Altorf-van der Kuil; Elizabeth J Brink; Martine Boetje; Els Siebelink; Sabina Bijlsma; Marielle F Engberink; Pieter van 't Veer; Daniel Tomé; Stephan J L Bakker; Marleen A van Baak; Johanna M Geleijnse Journal: Br J Nutr Date: 2013-03-04 Impact factor: 3.718
Authors: Yun Jin Pai; Kit-Yi Leung; Dawn Savery; Tim Hutchin; Helen Prunty; Simon Heales; Margaret E Brosnan; John T Brosnan; Andrew J Copp; Nicholas D E Greene Journal: Nat Commun Date: 2015-03-04 Impact factor: 14.919
Authors: Stephen R Williams; Qiong Yang; Fang Chen; Xuan Liu; Keith L Keene; Paul Jacques; Wei-Min Chen; Galit Weinstein; Fang-Chi Hsu; Alexa Beiser; Liewei Wang; Ebony Bookman; Kimberly F Doheny; Philip A Wolf; Michelle Zilka; Jacob Selhub; Sarah Nelson; Stephanie M Gogarten; Bradford B Worrall; Sudha Seshadri; Michèle M Sale Journal: PLoS Genet Date: 2014-03-20 Impact factor: 5.917
Authors: Joanna Nizioł; Krzysztof Ossoliński; Brian P Tripet; Valérie Copié; Adrian Arendowski; Tomasz Ruman Journal: Anal Bioanal Chem Date: 2020-07-13 Impact factor: 4.142